About
OptMed
Biosurgical
Adhesive
Products
Genitourinary
Therapeutic
Products
News &
Publications
Contact
Overview
Team
Board of Directors & Officers
Clinical Advisors
Platform Overview
Programs
BondEase®
Other Indications
Platform Overview
Programs
Overactive Bladder
Kidney Stones
News
Publications
Contact
January 12, 2016:
OptMed Receives FDA Marketing Clearance For Its Topical Surgical Skin Adhesive, BondEase®
CAUTION:
BondEase® is an investigational device. It has not been cleared for marketing or commercial sale in the United States.